{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:27:06Z","timestamp":1788960426821,"version":"build-2803163510"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CR00I5-236010"],"award-info":[{"award-number":["CR00I5-236010"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>BET-targeting PROteolysis TArgeting Chimeras (PROTACs) outperform their parent inhibitors in preclinical prostate cancer (PCa) models, yet their enhanced potency is expected to amplify dose-limiting on-target toxicities. To widen the therapeutic window, we designed a two-tier selective prodrug strategy enabling glutathione (GSH)-responsive and PCa-targeted delivery of the BET PROTAC MZ1 caged via a carbonate moiety. Our design integrates a prostate-specific membrane antigen (PSMA) ligand with a GSH-cleavable disulfide linker to achieve tumor-associated activation. Systematic optimization of the commonly used but hydrolytically labile carbonate\u2013disulfide motif led to secondary carbonate variant 2a with markedly improved stability. In cellular systems, this analogue demonstrated strong disulfide dependence, confirming tight GSH control over prodrug activation. Importantly, while resistance to premature hydrolysis was significantly enhanced compared to the primary carbonate, GSH-mediated cleavage and the subsequent MZ1-releasing cyclization step proceeded with minimal kinetic penalty. In contrast, selective PSMA-mediated uptake could not be demonstrated. Molecular dynamics simulations revealed unexpected intramolecular folding that generates a compact prodrug conformation in which acidic functionalities are effectively masked. This structural feature may promote passive membrane permeability, which underscores the complexity of dual-targeting strategies. Collectively, our study establishes design principles for stable yet GSH-responsive carbonate\u2013disulfide prodrugs and provides a framework for the rational development of PROTAC prodrugs, emphasizing the importance of coordinated optimization of their individual components to achieve predictable biological behavior.<\/jats:p>","DOI":"10.1021\/jacsau.6c00397","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:23:45Z","timestamp":1781123025000},"page":"3816-3827","source":"Crossref","is-referenced-by-count":1,"title":["Balancing Stability\nand Payload Release in Glutathione-Responsive\nPROTAC Prodrugs Targeting Prostate Cancer"],"prefix":"10.1021","volume":"6","author":[{"given":"Eleen","family":"Laul","sequence":"first","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9719-2013","authenticated-orcid":true,"given":"Katherine A.","family":"Gossele\u0301","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0924-6564","authenticated-orcid":true,"given":"Christian M.","family":"Matter","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong W.","family":"Liu","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Gonza\u0301lez","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-219X","authenticated-orcid":true,"given":"Jason P.","family":"Holland","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-6792","authenticated-orcid":true,"given":"Amedeo","family":"Caflisch","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-581X","authenticated-orcid":true,"given":"Cristina","family":"Nevado","sequence":"additional","affiliation":[{"name":"University of Zurich , , Winterthurerstrasse 190 , ,","place":["Zu\u0308rich, Switzerland, 8057"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"2","key":"2026073100183580500_cit1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced Protein Degradation: An Emerging Drug Discovery\nParadigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"3","key":"2026073100183580500_cit2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC\nTargeted Protein Degraders:\nThe Past Is Prologue","volume":"21","author":"Be\u0301ke\u0301s","year":"2022","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"26","key":"2026073100183580500_cit3","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-Induced\nBET Protein Degradation as a Therapy for Castration-Resistant Prostate\nCancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026073100183580500_cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113922","article-title":"Identification\nof a Selective BRD4 PROTAC with Potent Antiproliferative Effects in\nAR-Positive Prostate Cancer Based on a Dual BET\/PLK1 Inhibitor","volume":"227","author":"Hu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"2026073100183580500_cit5","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073043","article-title":"BET Bromodomain\nInhibitors: Novel Design Strategies and Therapeutic Applications","volume":"28","author":"To","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"2026073100183580500_cit6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02024-9","article-title":"New-Generation\nAdvanced PROTACs as Potential Therapeutic Agents in Cancer Therapy","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"12","key":"2026073100183580500_cit7","first-page":"2321","article-title":"Enhanced Expression of Prostate-Specific\nMembrane Antigen\nGene in Prostate Cancer as Revealed by in Situ Hybridization","volume":"57","author":"Kawakami","year":"1997","journal-title":"Cancer Res."},{"issue":"12","key":"2026073100183580500_cit8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/1055-9965.EPI-13-0668","article-title":"Prostate-Specific\nMembrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal\nProstate Cancer","volume":"22","author":"Kasperzyk","year":"2013","journal-title":"Cancer Epidemiol., Biomarkers\nPrev."},{"issue":"4","key":"2026073100183580500_cit9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of Prostate-Specific\nMembrane\nAntigen in Normal and Malignant Human Tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J. Surg."},{"issue":"9","key":"2026073100183580500_cit10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","article-title":"FDA Approval\nSummary: Lutetium Lu\n177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant\nProstate Cancer","volume":"29","author":"Fallah","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"2026073100183580500_cit11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for Metastatic Castration-Resistant\nProstate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"2026073100183580500_cit12","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1021\/acs.jmedchem.5c00226","article-title":"PSMA-Guided PROTAC\nDegraders for Tumor-Specific Protein Degradation in Prostate Cancer","volume":"68","author":"Meng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026073100183580500_cit13","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1021\/jacs.4c18398","article-title":"A Dual-Targeted\nMolecule for Disease-Activatable\nProteolysis Targeting Chimeras and Targeted Radionuclide Therapy of\nCancer","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026073100183580500_cit14","doi-asserted-by":"crossref","unstructured":"Cai, D.; Li, C.; Idrissou, M. B.; Hawkins, N.; Mudududdla, R.; Chen, X.; Nguyen, T.-V.; Li, X.; Hernandez, R.; Tang, W.\n          Development of Prostate Cancer-Targeting BRD4 Intramolecular\nBivalent Molecular Glue Degraders\n          ChemRxiv\n          2024\n          10.26434\/chemrxiv-2024-1jb15.","DOI":"10.26434\/chemrxiv-2024-1jb15"},{"issue":"8","key":"2026073100183580500_cit15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","article-title":"Glutathione\nLevels\nin Human Tumors","volume":"17","author":"Gamcsik","year":"2012","journal-title":"Biomarkers"},{"issue":"2\u20133","key":"2026073100183580500_cit16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0300-483X(95)03221-Z","article-title":"Variability\nin Glutathione-Dependent\nDetoxication in Vivo and Its Relevance to Detoxication of Chemical\nMixtures","volume":"105","author":"Jones","year":"1995","journal-title":"Toxicology"},{"issue":"3","key":"2026073100183580500_cit17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/med.22007","article-title":"Glutathione-triggered\nProdrugs: Design Strategies, Potential Applications, and Perspectives","volume":"44","author":"Zhao","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"3","key":"2026073100183580500_cit18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1039\/D2CS00673A","article-title":"The Design of Small-Molecule\nProdrugs\nand Activatable Phototherapeutics for Cancer Therapy","volume":"52","author":"Han","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"2026073100183580500_cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122353","article-title":"Smart Chemistry\nfor Traceless Release of Anticancer\nTherapeutics","volume":"303","author":"Prange","year":"2023","journal-title":"Biomaterials"},{"issue":"5","key":"2026073100183580500_cit20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1023\/A:1018987111362","article-title":"Hydrolysis of Carbonates, Thiocarbonates,\nCarbamates, and Carboxylic Esters of \u03b1-Naphthol, \u03b2-Naphthol,\nand p-Nitrophenol by Human, Rat, and Mouse Liver Carboxylesterases","volume":"10","author":"Huang","year":"1993","journal-title":"Pharm. Res."},{"issue":"6","key":"2026073100183580500_cit21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1158\/1535-7163.MCT-12-1170","article-title":"Milatuzumab\u2013SN-38 Conjugates for the Treatment\nof CD74+ Cancers","volume":"12","author":"Govindan","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"2026073100183580500_cit22","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/jacsau.4c00298","article-title":"Modular Development\nof Enzyme-Activatable Proteolysis Targeting Chimeras\nfor Selective Protein Degradation and Cancer Targeting","volume":"4","author":"Chen","year":"2024","journal-title":"JACS Au"},{"issue":"16","key":"2026073100183580500_cit23","doi-asserted-by":"publisher","first-page":"17323","DOI":"10.1021\/acs.jmedchem.5c00862","article-title":"Small Molecule\u2013Degrader\nConjugates: Evaluating the Structure\u2013Activity Relationship\nof Linkers to Overcome In Vivo Barriers in PROTAC Delivery","volume":"68","author":"Song","year":"2025","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026073100183580500_cit24","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective\nSmall Molecule Induced\nDegradation of the BET Bromodomain Protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"2026073100183580500_cit25","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/0008-5472.CAN-20-1624","article-title":"Cytoplasmic\nLocalization of Prostate-Specific\nMembrane Antigen Inhibitors May Confer Advantages for Targeted Cancer\nTherapies","volume":"81","author":"Matthias","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"2026073100183580500_cit26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13312","article-title":"Potent and Selective\nChemical Probe\nof Hypoxic Signalling Downstream of HIF-\u03b1 Hydroxylation via\nVHL Inhibition","volume":"7","author":"Frost","year":"2016","journal-title":"Nat. Commun."},{"issue":"25","key":"2026073100183580500_cit27","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1021\/jm990145k","article-title":"Quantitative Structure-Metabolism\nRelationships: Steric and Nonsteric\nEffects in the Enzymatic Hydrolysis of Noncongener Carboxylic Esters","volume":"42","author":"Buchwald","year":"1999","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026073100183580500_cit28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1023\/A:1018987111362","article-title":"Hydrolysis of Carbonates, Thiocarbonates,\nCarbamates, and Carboxylic Esters of Alpha-Naphthol, Beta-Naphthol,\nand p-Nitrophenol by Human, Rat, and Mouse Liver Carboxylesterases","volume":"10","author":"Huang","year":"1993","journal-title":"Pharm. Res."},{"key":"2026073100183580500_cit29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bioorg.2013.06.007","article-title":"Mutual Prodrugs Containing Bio-Cleavable\nand Drug Releasable Disulfide Linkers","volume":"49","author":"Jain","year":"2013","journal-title":"Bioorg.\nChem."},{"issue":"1\u20133","key":"2026073100183580500_cit30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and\nComputational Approaches to Estimate Solubility and Permeability in\nDrug Discovery and Development Settings 1PII of Original Article:\nS0169\u2013409X(96)00423\u20131. The Article Was Originally Published\nin Advanced Drug Delivery Reviews 23 (1997) 3\u201325. 1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Delivery Rev."},{"issue":"15","key":"2026073100183580500_cit31","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1021\/acs.jmedchem.4c01017","article-title":"Structural and Physicochemical\nFeatures of Oral PROTACs","volume":"67","author":"Schade","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026073100183580500_cit32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1021\/acs.jmedchem.4c02492","article-title":"Impact of Linker Composition on VHL PROTAC Cell Permeability","volume":"68","author":"Abeje","year":"2025","journal-title":"J. Med. Chem."},{"issue":"19","key":"2026073100183580500_cit33","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1021\/acs.jmedchem.2c00877","article-title":"Linker-Dependent Folding\nRationalizes PROTAC Cell Permeability","volume":"65","author":"Poongavanam","year":"2022","journal-title":"J. Med.\nChem."},{"issue":"1","key":"2026073100183580500_cit34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/acsmedchemlett.0c00556","article-title":"Solution Conformations\nShed Light on PROTAC Cell Permeability","volume":"12","author":"Atilaw","year":"2021","journal-title":"ACS\nMed. Chem. Lett."},{"issue":"1","key":"2026073100183580500_cit35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41570-023-00563-1","article-title":"Molecular Chameleons in Drug Discovery","volume":"8","author":"Poongavanam","year":"2024","journal-title":"Nat. Rev. Chem."},{"issue":"7","key":"2026073100183580500_cit36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/pros.22789","article-title":"Improving the Biodistribution\nof PSMA-Targeting Tracers\nwith a Highly Negatively Charged Linker","volume":"74","author":"Huang","year":"2014","journal-title":"Prostate"},{"issue":"11","key":"2026073100183580500_cit37","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/1535-7163.MCT-14-0422","article-title":"Development of Targeted\nNear-Infrared Imaging Agents\nfor Prostate Cancer","volume":"13","author":"Wang","year":"2014","journal-title":"Mol. Cancer Ther."}],"container-title":["JACS Au"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jacsau.6c00397","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jaaucr\/article-pdf\/6\/7\/3816\/66280857\/jacsau.6c00397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jaaucr\/article-pdf\/6\/7\/3816\/66280857\/jacsau.6c00397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:18:43Z","timestamp":1785471523000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jaaucr\/article\/6\/7\/3816\/5234019\/Balancing-Stability-and-Payload-Release-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,10]]},"published-print":{"date-parts":[[2026,7,27]]}},"URL":"https:\/\/doi.org\/10.1021\/jacsau.6c00397","relation":{},"ISSN":["2691-3704"],"issn-type":[{"value":"2691-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}